| Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosis SH Cho, S Warit, B Wan, CH Hwang, GF Pauli, SG Franzblau Antimicrobial agents and chemotherapy 51 (4), 1380-1385, 2007 | 366 | 2007 |
| Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis SG Franzblau, MA DeGroote, SH Cho, K Andries, E Nuermberger, ... Tuberculosis 92 (6), 453-488, 2012 | 254 | 2012 |
| New perspectives on natural products in TB drug research GF Pauli, RJ Case, T Inui, Y Wang, S Cho, NH Fischer, SG Franzblau Life sciences 78 (5), 485-494, 2005 | 213 | 2005 |
| Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity GC Moraski, LD Markley, PA Hipskind, H Boshoff, S Cho, SG Franzblau, ... ACS medicinal chemistry letters 2 (6), 466-470, 2011 | 196 | 2011 |
| The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo W Gao, JY Kim, JR Anderson, T Akopian, S Hong, YY Jin, O Kandror, ... Antimicrobial agents and chemotherapy 59 (2), 880-889, 2015 | 185 | 2015 |
| A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents JG Hurdle, RB Lee, NR Budha, EI Carson, J Qi, MS Scherman, SH Cho, ... Journal of antimicrobial chemotherapy 62 (5), 1037-1045, 2008 | 130 | 2008 |
| New tuberculosis drug targets, their inhibitors, and potential therapeutic impact GS Shetye, SG Franzblau, S Cho Translational Research 220, 68-97, 2020 | 128 | 2020 |
| Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo [1, 2-a] pyridines and isomeric … GC Moraski, LD Markley, M Chang, S Cho, SG Franzblau, CH Hwang, ... Bioorganic & medicinal chemistry 20 (7), 2214-2220, 2012 | 125 | 2012 |
| QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity MN Gomes, RC Braga, EM Grzelak, BJ Neves, E Muratov, R Ma, LL Klein, ... European journal of medicinal chemistry 137, 126-138, 2017 | 111 | 2017 |
| Microplate Alamar Blue Assay (MABA) and Low Oxygen Recovery Assay (LORA) for Mycobacterium tuberculosis S Cho, HS Lee, S Franzblau Mycobacteria protocols, 281-292, 2015 | 107 | 2015 |
| In Vitro and In Vivo Activities of the Nitroimidazole TBA-354 against Mycobacterium tuberculosis AM Upton, S Cho, TJ Yang, Y Kim, Y Wang, Y Lu, B Wang, J Xu, K Mdluli, ... Antimicrobial Agents and Chemotherapy 59 (1), 136-144, 2015 | 106 | 2015 |
| Rufomycin targets ClpC1 proteolysis in Mycobacterium tuberculosis and M. abscessus MP Choules, NM Wolf, H Lee, JR Anderson, EM Grzelak, Y Wang, R Ma, ... Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 02204-18, 2019 | 88 | 2019 |
| Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model SS Grant, T Kawate, PP Nag, MR Silvis, K Gordon, SA Stanley, ... ACS chemical biology 8 (10), 2224-2234, 2013 | 86 | 2013 |
| In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide R Villar, E Vicente, B Solano, S Pérez-Silanes, I Aldana, JA Maddry, ... Journal of Antimicrobial Chemotherapy 62 (3), 547-554, 2008 | 86 | 2008 |
| Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB GC Moraski, N Seeger, PA Miller, AG Oliver, HI Boshoff, S Cho, ... ACS Infectious Diseases 2 (6), 393-398, 2016 | 81 | 2016 |
| Anti‐TB polyynes from the roots of Angelica sinensis S Deng, Y Wang, T Inui, SN Chen, NR Farnsworth, S Cho, SG Franzblau, ... Phytotherapy Research 22 (7), 878-882, 2008 | 79 | 2008 |
| Design, synthesis and investigation on the structure–activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents M Pieroni, B Wan, S Cho, SG Franzblau, G Costantino European journal of medicinal chemistry 72, 26-34, 2014 | 77 | 2014 |
| ICAT-based comparative proteomic analysis of non-replicating persistent Mycobacterium tuberculosis SH Cho, D Goodlett, S Franzblau Tuberculosis 86 (6), 445-460, 2006 | 73 | 2006 |
| Efficacy of Quinoxaline-2-Carboxylate 1,4-Di-N-Oxide Derivatives in Experimental Tuberculosis E Vicente, R Villar, A Burguete, B Solano, S Pérez-Silanes, I Aldana, ... Antimicrobial agents and chemotherapy 52 (9), 3321-3326, 2008 | 72 | 2008 |
| Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening EM Grzelak, MP Choules, W Gao, G Cai, B Wan, Y Wang, JB McAlpine, ... The Journal of antibiotics 72 (10), 719-728, 2019 | 68 | 2019 |
